MyFinsight
Home
Blog
About
Back
Income Statement
AEON Biopharma, Inc. (AEON)
AEON Biopharma, Inc. (AEON)
source: myfinsight.com
Net (loss) income
-$1,155K
(82.61%↑ Y/Y)
Change in fair value of
warrants
-$4,941K
(-1011.62%↓ Y/Y)
Other income, net
$36K
(-60.87%↓ Y/Y)
(loss) income before
taxes
-$1,155K
(82.61%↑ Y/Y)
Total other (loss)
income, net
$4,764K
(306.77%↑ Y/Y)
Change in fair value of
convertible notes
-$213K
(88.51%↑ Y/Y)
Loss from operations
-$5,919K
(-36.45%↓ Y/Y)
Total operating costs
and expenses
$5,919K
(36.45%↑ Y/Y)
Change in fair value of
contingent consideration
-$10K
(-162.50%↓ Y/Y)
Selling, general and
administrative
$2,991K
(-8.20%↓ Y/Y)
Research and development
$2,938K
(176.13%↑ Y/Y)
Back